Istiratumab Biosimilar – Anti-ERBB3, IGF1R, CD221 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1-kappa -[scFv]2

Brand

Product type

Clonality

Expression system

Applications

,

Product nameIstiratumab Biosimilar - Anti-ERBB3, IGF1R, CD221 mAb - Research Grade
SourceCAS 1509928-04-4
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsIstiratumab,MM-005,MM-141,ERBB3, IGF1R, CD221,anti-ERBB3, IGF1R, CD221
ReferencePX-TA1381
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa -[scFv]2
ClonalityMonoclonal Antibody

Description of Istiratumab Biosimilar - Anti-ERBB3, IGF1R, CD221 mAb - Research Grade

General information on Anti-ERBB3/IGF1R/CD221[Homo sapiens] (Istiratumab) Monoclonal Antibody

Istiratumab is investigated for the treatment of Front-line Metastatic Pancreatic Cancer.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Istiratumab Biosimilar – Anti-ERBB3, IGF1R, CD221 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

Receptor tyrosine-protein kinase erbB-3(ERBB3)Fc Tag
Antigen

Receptor tyrosine-protein kinase erbB-3(ERBB3)Fc Tag

PX-P4725 210€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products